• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® EGFR MUTATION TEST V2; SOMATIC GENE MUTATION DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® EGFR MUTATION TEST V2; SOMATIC GENE MUTATION DETECTION SYSTEM Back to Search Results
Catalog Number 07248563190
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/27/2022
Event Type  malfunction  
Manufacturer Narrative
The investigation is on-going.A supplemental mdr will be filed upon completion of the investigation.
 
Event Description
A customer from spain alleged discrepant results for one patient when using the cobas egfr mutation test v2.The alleged sample was initially tested using the cobas egfr mutation test v2 and generated a "no mutation detected" result.A retest was performed using next generation sequencing (ngs) which detected l858r (vaf 7%).The sample was retested once again on the cobas egfr mutation test v2 and generated "mutation detected" result for l858r.No harm alleged.An investigation is ongoing to evaluate the customer issue.
 
Manufacturer Narrative
No product problem was identified.The discordant results are due to the sample being near the limit of detection (lod) of our assay.Samples near the lod can waver between "detected" and "no mutation detected" with repeat testing.Per the method sheet, a "no mutation detected" result does not preclude the presence of a mutation in the targeted egfr regions because results depend on percent mutant sequences, adequate sample integrity, absence of inhibitors, and sufficient dna to be detected.Of note, the 4 slides from ffpet used are from a "real sample", which is not expected to have any of its result reported out, just for laboratory certification and result concordance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS® EGFR MUTATION TEST V2
Type of Device
SOMATIC GENE MUTATION DETECTION SYSTEM
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer (Section G)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
na
branchburg NJ 08876
Manufacturer Contact
timothy blair
1080 us hwy 202 s
building 500, room: 3530
branchburg, NJ 08876
9253534412
MDR Report Key16037680
MDR Text Key308371987
Report Number2243471-2022-01073
Device Sequence Number1
Product Code OWD
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P150047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07248563190
Device Lot NumberASKU
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/30/2022
Initial Date FDA Received12/22/2022
Supplement Dates Manufacturer Received01/13/2023
Supplement Dates FDA Received01/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-